About Krajska Nemocnice Pardubice Neurologicka Klinika
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Krajska Nemocnice Pardubice Neurologicka Klinika
During the past decade, Krajska Nemocnice Pardubice Neurologicka Klinika conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on
average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis
2008-07-17
2023-12-16
Active, not recruiting
220
A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer
2009-10-16
2017-01-24
Completed
596
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
2011-08-31
2022-12-31
Completed
821
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
2011-09-20
2022-12-30
Completed
835
A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations
2018-11-06
2021-06-15
Completed
630
Open Label Extension (OLE) Study of the Safety and Clinical Utility of IPX203 in PD Patients With Motor Fluctuations
2019-04-03
2022-03-21
Completed
420
A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple Sclerosis
2022-05-03
2025-02-22
Recruiting
234
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Krajska Nemocnice Pardubice Neurologicka Klinika"
#1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Krajska Nemocnice Pardubice Neurologicka Klinika
According to Clinical.Site data, the most researched conditions in "Krajska Nemocnice Pardubice Neurologicka Klinika" are
"Relapsing Multiple Sclerosis" (3 trials), "Breast Cancer" (1 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials), "Parkinson Disease" (1 trials) and "Parkinson's Disease (Disorder)" (1 trials). Many other conditions were trialed in "Krajska Nemocnice Pardubice Neurologicka Klinika" in a lesser frequency.
Clinical Trials Intervention Types at Krajska Nemocnice Pardubice Neurologicka Klinika
Most popular intervention types in "Krajska Nemocnice Pardubice Neurologicka Klinika" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ocrelizumab" (3 trials), "Interferon beta-1a" (2 trials), "Interferon beta-1a-matching placebo" (2 trials), "Ocrelizumab-matching placebo" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Krajska Nemocnice Pardubice Neurologicka Klinika
The vast majority of trials in "Krajska Nemocnice Pardubice Neurologicka Klinika" are
6 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Krajska Nemocnice Pardubice Neurologicka Klinika
Currently, there are NaN active trials in "Krajska Nemocnice Pardubice Neurologicka Klinika".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Krajska Nemocnice Pardubice Neurologicka Klinika,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Krajska Nemocnice Pardubice Neurologicka Klinika, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".